Literature DB >> 21507694

Immune cells in adipose tissue: key players in metabolic disorders.

K Lolmède1, C Duffaut, A Zakaroff-Girard, A Bouloumié.   

Abstract

Obesity, defined as the excess development of adipose tissue, is an important risk factor for metabolic and cardiovascular diseases such as type 2 diabetes, hypertension and atherosclerosis. Over the past few years, metabolic inflammation has emerged as a major process underlying the link between obesity and its associated pathologies. Adipose tissue appears to play a primary and crucial role as a source and site of inflammation. Accumulation of immune cells within adipose tissue occurs in obese conditions. The present review focuses on the relationship between adipose tissue and immune cells, including macrophages, dendritic cells, T and B lymphocytes, and natural killer cells, in both the physiological state and under obese conditions. The factors involved in the accumulation of both myeloid and lymphoid cells in adipose tissue are also described. In addition, the role of adipose-tissue immune cells on adipocyte metabolism and cells of the adipose tissue stromal-vascular fraction are discussed, with particular emphasis on the cross-talk between macrophages and adipocytes, together with recent reports of T lymphocytes in adipose tissue.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507694     DOI: 10.1016/j.diabet.2011.03.002

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  41 in total

1.  Systemically delivered adipose stromal vascular fraction cells disseminate to peripheral artery walls and reduce vasomotor tone through a CD11b+ cell-dependent mechanism.

Authors:  Marvin E Morris; Jason E Beare; Robert M Reed; Jacob R Dale; Amanda J LeBlanc; Christina L Kaufman; Huaiyu Zheng; Chin K Ng; Stuart K Williams; James B Hoying
Journal:  Stem Cells Transl Med       Date:  2015-02-26       Impact factor: 6.940

Review 2.  'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.

Authors:  Laura M Pérez; Helios Pareja-Galeano; Fabián Sanchis-Gomar; Enzo Emanuele; Alejandro Lucia; Beatriz G Gálvez
Journal:  J Physiol       Date:  2016-05-10       Impact factor: 5.182

Review 3.  Lymphocytes in obesity-related adipose tissue inflammation.

Authors:  A Chatzigeorgiou; K P Karalis; S R Bornstein; T Chavakis
Journal:  Diabetologia       Date:  2012-06-26       Impact factor: 10.122

Review 4.  Obesity and weight loss could alter the properties of adipose stem cells?

Authors:  Leandra S Baptista; Karina R Silva; Radovan Borojevic
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Low-Grade Inflammation, Obesity, and Diabetes.

Authors:  Solange S Pereira; Jacqueline I Alvarez-Leite
Journal:  Curr Obes Rep       Date:  2014-12

6.  Reduced antioxidant capacity and increased subclinical inflammation markers in prepubescent obese children and their relationship with nutritional markers and metabolic parameters.

Authors:  Aysel Vehapoglu; Serdar Turkmen; Nilufer Goknar; Ömer Faruk Özer
Journal:  Redox Rep       Date:  2016-02-19       Impact factor: 4.412

Review 7.  Can Brown Fat Win the Battle Against White Fat?

Authors:  Sawsan Elattar; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

Review 8.  Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.

Authors:  W Timothy Garvey; Jeffrey I Mechanick
Journal:  Obesity (Silver Spring)       Date:  2020-03       Impact factor: 5.002

9.  Cellular heterogeneity in superficial and deep subcutaneous adipose tissues in overweight patients.

Authors:  Nathalie Boulet; David Estève; Anne Bouloumié; Jean Galitzky
Journal:  J Physiol Biochem       Date:  2012-11-25       Impact factor: 4.158

Review 10.  n-3 Polyunsaturated fatty acids modulate metabolism of insulin-sensitive tissues: implication for the prevention of type 2 diabetes.

Authors:  Alexandre Pinel; Béatrice Morio-Liondore; Frédéric Capel
Journal:  J Physiol Biochem       Date:  2013-12-27       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.